Adare Pharma Solutions

Learn about the biggest trends impacting small-molecule APIs, excipients, and formulations, key sessions to attend while at CPHI, innovations and novel approaches for pediatric dosage forms and taste-masking, and fundamental aspects of API manufacturing and distribution from a panel of experts who have contributed to this year’s CPHI Annual Report, David Tisi from Synopsys, and an SME from C2 Pharma in this episode of the PharmTech Drug Digest Video Series.

https://www.pharmtech.com/pt_w/big-impact

In this exclusive Drug Digest video interview, Felicity Thomas, Europe/senior editor, 

Group, interviews experts about small-molecule APIs, excipients, and formulation advances. During the video session, a panel of experts—Bikash Chatterjee, Tara Dougal —deliberate on the biggest trends impacting the industry, highlighting issues such as API supply and shortages, uptake in digital innovations, formulation advances to deal with potent compounds, and key sessions to visit while at CPHI. Additionally, David Tisi, director of Technical Operations, Synopsys, discusses novel approaches and solutions to pediatric formulations and taste-masking, while an expert from C2 Pharma highlights the fundamental stages of gaining a certificate of suitability for APIs and the various trends shaping API and complex compound manufacturing.
Interviews featuring:

Bikash Chatterjee, president and chief science officer at PharmTech Associates

Tara Dougal, content director—Pharma, Informa Markets

Tara Fitzpatrick, head of Quality, C2 Pharma

This episode of Drug Digest is sponsored by:

Trends impacting small-molecule APIs, excipients, and formulation markets.

Innovations benefitting API and excipient developers and formulation scientists.

Novel approaches to pediatric formulations.

Fundamental stages of gaining a certificate of suitability.


Director of Technical Operations
Synopsys


Webcasts

Webinar Date/Time: Thursday, September 21, 2023 at 11am ET | 10am CT | 8am PT | 4 pm BST

A Big Impact: Trends Shaping Small-Molecule APIs, Excipients, and Formulations

Videos

An interview with Tom Sellig the Chief Executive Officer of Adare Pharma Solutions at the CPHI Conference in Frankfurt, Germany. 

The Journey to Building a Client Centric CDMO

Articles

DuraGran® reduces the excipients and/or steps to build beads or granules, and at higher concentrations, spheronization and extrusion steps typically used can be forgoed.


Reducing Drug-layering Production Time And Costs

Patient adherence to a drug dosing regimen is crucial to any treatment plan. Formulating drugs to facilitate adherence is an ongoing industry challenge. New formulations developed with the patient in mind can also extend the lifecycle of a drug product.

In this webcast, learn about patient adherence concerns, challenges encountered when formulating drugs with a patient-centric focus, and clinical recommendations for pediatric dosage forms. The discussion will also review repurposing strategies for formulation development and case studies demonstrating technology platforms that can be used to optimize oral dosage forms for patient-centric products.

Join the webinar to learn how you can apply these strategies for your products today.

Understand patient-centric dosing challenges

Review patient adherence and clinical recommendations for pediatric dosage forms

Learn about formulation challenges and how technology platforms can optimize oral dosage forms to create patient-centric products

Review patient-centric formulation strategies regarding drug product lifecycle management

R&D scouting technology innovation directors/managers


Clinical Professor
Ernest Mario School of Pharmacy, Rutgers University


Senior Director, Pharmaceutical Sciences, Business Support, and New Technologies
Adare Pharma Solutions


SVP Corporate Strategy and New Product Planning
Azurity Pharmaceutical

Thursday, September 30, 2021 at 1pm EDT| 12pm CDT| 10am PDT
Formulating drugs to facilitate patient adherence, especially for pediatrics, is an ongoing industry challenge. Learn about challenges encountered when formulating drugs with a patient-centric focus, clinical recommendations for pediatric dosage forms, repurposing strategies for formulation development, and technology platforms to optimize oral dosage forms. 

Strategies for Effective Patient-Centric Dosage Formulations

Multiparticulate systems have several advantages over conventional tablet or capsule formulations. Download this whitepaper to learn more.